Tag: cell carcinoma

September 8, 2017 Off

Cemiplimab gets FDA breakthrough therapy designation for certain cell carcinoma

Sanofi and Regeneron Pharmaceuticals, said on Friday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to…

November 19, 2015 Off

Biofrontera concludes clinical phase III of BCC study. Approval of Ameluz expected in 2016

By Dino Mustafić

Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.